PubRank

Jean-Louis Touraine

Author PubWeight™ 21.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rheumatoid arthritis after 9 years of human immunodeficiency virus infection: possible contribution of tritherapy. J Rheumatol 2002 1.38
2 High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo. Cancer Res 2011 1.34
3 Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients. Emerg Infect Dis 2004 1.31
4 Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006 1.15
5 A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation 2003 1.13
6 Telmisartan is a potent target for prevention and treatment in human prostate cancer. Oncol Rep 2008 1.07
7 Telmisartan inhibits human urological cancer cell growth through early apoptosis. Exp Ther Med 2010 0.92
8 Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation. Transpl Immunol 2009 0.91
9 Clinical features of acute retroviral syndrome differ by route of infection but not by gender and age. J Acquir Immune Defic Syndr 2002 0.88
10 The incidence of herpes zoster is less likely than other opportunistic infections to be reduced by highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2005 0.87
11 Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine. Transpl Immunol 2010 0.87
12 Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice. PLoS One 2013 0.85
13 Retracted Immunosuppressive networks in the tumour environment and their effect in dendritic cells. Biochim Biophys Acta 2008 0.85
14 Telmisartan as a peroxisome proliferator-activated receptor-γ ligand is a new target in the treatment of human renal cell carcinoma. Mol Med Rep 2011 0.83
15 The recent increase of syphilis cases in Lyon University hospitals Is mainly observed in HIV-infected patients: descriptive data from a laboratory-based surveillance system. J Acquir Immune Defic Syndr 2003 0.82
16 No recurrence of posttransplantation Kaposi's sarcoma three years after renal retransplantation. Transplantation 2002 0.80
17 Expression of cysteinylLT1 receptor in human testicular cancer and growth reduction by its antagonist through apoptosis. Mol Med Rep 2011 0.78
18 First presentation for care of HIV-infected patients with low CD4 cell count in Lyon, France: risk factors and consequences for survival. AIDS Care 2012 0.78
19 Relationship between peroxisome proliferator-activated receptor-γ and renal ischemia-reperfusion injury. Mol Med Rep 2011 0.78
20 Different mechanisms are involved in apoptosis induced by melanoma gangliosides on human monocyte-derived dendritic cells. Glycobiology 2009 0.78
21 [Infectious complications due to immunosuppression in organ transplant patients]. Rev Prat 2007 0.77
22 Hepatocyte growth factor (HGF) as a rapid diagnostic marker and its potential in the prevention of acute renal rejection. Transpl Int 2002 0.76
23 Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene. Transpl Immunol 2004 0.76
24 The role of arachidonic acid in a rat renal ischemia-reperfusion injury model. Mol Med Rep 2011 0.76
25 Factors associated with the time elapsed between initial detection of HIV antibodies and first contact for healthcare in HIV seroconverters of the Lyon University Hospitals. J Acquir Immune Defic Syndr 2002 0.75
26 HIV-1 infection: functional competition between gp41 and interleukin-2. C R Biol 2010 0.75
27 The role of the transplant physician in the management of skin cancers after organ transplantation. Cancer Treat Res 2009 0.75
28 Administration of the selective cyclooxygenase (COX)-2 inhibitor etodolac prolongs cardiac allograft survival in a mouse model. Mol Med Rep 2010 0.75
29 Expression of sphingosine-1 phosphate receptor in rat renal ischemia-reperfusion injury. Mol Med Rep 2011 0.75
30 Kidney transplant and cryptic hepatitis. Lancet 2009 0.75
31 Prope tolerance to heart allografts in mice associated with persistence of donor interleukin-10-transduced stem cells. Transplantation 2012 0.75
32 The effect of neutrophil elastase inhibitor on acute tubular necrosis after renal ischemia-reperfusion injury. Mol Med Rep 2011 0.75